McKinsey acknowledged in its statement that some staff members consulted for opioid makers and the FDA simultaneously, but added that its consulting work for the FDA wasn't drug-related.
"McKinsey's work for the FDA has focused on administrative and operational topics, including improvements to organizational structures, business processes and technology," the statement read."We have not advised the FDA on regulatory decisions or on specific pharmaceutical products."In its statement, McKinsey added that it plans to cooperate with the House committee to address any additional questions.
The report found that McKinsey completed 76 consulting contracts with the FDA between 2008 and 2022, which netted the company $140 million. Between 2004 and 2019, McKinsey completed 75 contracts with Purdue Pharma or its affiliates, according to the report. Some of the McKinsey staffers who consulted for both the FDA and Purdue Pharma included senior consultants Navjot Singh and Jeff Smith, the report found.
The committee report also states that McKinsey tried to convince opioid manufacturers on three separate occasions — through email and in-person presentations — to sign up for additional consulting contracts centered on increasing sales of opioids. In one incident in 2009, McKinsey gave a slide presentation pitching its capabilities to a group of drug manufacturers. In a bullet point detailing its experience McKinsey states that it has"Supported regulatory bodies directly, and as such has developed insights into the perspectives of the regulators themselves."America's Opioid Epidemic
Ah the pinks I miss the old days but I'm grown now too much to do not enough time to get wasted.
Left out the plan of Sacklers to indoctrinate doctors with “focus groups”. The lying they got fined for was theyKnew!!! OxyContin was MORE addictive. Told drs that they were under medicating pain and their patients were suffering.1/2 million deaths to date - unconscionable